BioIQ Adds Antibody Testing to its COVID-19 Testing Platform
BioIQ, a healthcare engagement and clinical adherence technology platform company, announces the addition of antibody testing to the company’s innovative COVID-19 population health solutions, including saliva RT-PCR diagnostic testing, for health plans, employers and government agencies. The recently added enzyme-linked immunosorbent assay (ELISA) test is the preferred standard in antibody testing and uses a blood or serum sample to determine whether an immunoglobulin (IgG/IgM) antibody is present in the test subject.
Read More